Univest
Univest
  • Markets

Kwality Pharmaceuticals Ltd. (KPL) 52 Week High Streak: What the Repeated Highs Mean

  • November 19, 2026
  • Posted by: Chaitanya Auti
  • Category: News
No Comments
Kwality Pharmaceuticals Ltd. 52 Week High Streak
Kwality Pharmaceuticals Ltd. (KPL) share price is trading within 2% of its 52-week high today and stood at Rs 4,192.5, down 0.07% from the previous close. Market cap was Rs 4,195.25 crore.

Kwality Pharmaceuticals Ltd. 52 Week High Streak has now lasted for its second straight session, with the stock trading within 2% of its 52-week high across the streak and advancing 3.69% over that stretch. As of 19 November 2026 at 9:22 AM IST, the stock’s latest high of Rs 4,274.75 and last traded price of Rs 4,192.50 keep it close to the yearly peak, while latest Univest data confirms the price pattern but does not establish a company-specific catalyst for the repeated move.

The previous session’s reference point is important because the pattern is not just about one intraday print. Kwality Pharmaceuticals Ltd. had a previous close of Rs 4,195.25, opened at Rs 4,230 and moved between Rs 4,177.10 and Rs 4,274.75 in the current session. The company’s market capitalisation stands at Rs 4,195.25 crore. For readers, this repeated-high setup is different from a one-off breakout: it shows the stock is staying near its one-year peak across more than one session, which can keep attention on the price zone and on any fresh fundamental updates that may follow.

Table of Contents

Toggle
  • Kwality Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis
  • What the Repeated 52-Week Highs Show
  • Kwality Pharmaceuticals Ltd. (KPL) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Kwality Pharmaceuticals Ltd.
  • About Kwality Pharmaceuticals Ltd.
  • Frequently Asked Questions
    • What does Kwality Pharmaceuticals Ltd. 52 Week High Streak mean?
    • How many sessions has Kwality Pharmaceuticals Ltd. stayed near its 52-week high?
    • What is the cumulative move across the streak?
    • Does the latest data confirm a company-specific catalyst?
    • How did the share price trade today?
    • How does the valuation compare with peers?
    • What do the profitability ratios show?
    • Why do investors track a repeated near-high pattern?
  • Track Kwality Pharmaceuticals Ltd. (KPL) Share Price on Univest

Kwality Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis

Metric Value
Current Price Rs 4,192.5
Previous Close Rs 4,195.25
Today's Move Rs -2.75 (-0.07%)
Open Rs 4,230
High Rs 4,274.75
Low Rs 4,177.1
Market Capitalisation Rs 4,195.25 crore

Kwality Pharmaceuticals Ltd. (KPL) traded at Rs 4,192.5 versus the previous close of Rs 4,195.25, a fall of 0.07%. The stock opened at Rs 4,230, reached a high of Rs 4,274.75 and touched a low of Rs 4,177.1.

Kwality Pharmaceuticals Ltd. is trading at Rs 4,192.50, which is Rs 2.75 below the previous close of Rs 4,195.25 and marks a marginal decline of 0.07%. The intraday move has been modest, but the stock has still remained close to its 52-week high zone throughout the current phase. That is the main takeaway for readers following the Kwality Pharmaceuticals Ltd. 52 Week High Streak: the stock is not drifting away from the peak area even when the day’s change is small.

The session opened at Rs 4,230 and touched a high of Rs 4,274.75 before moving to a low of Rs 4,177.10. That range places the latest price in the upper half of the day’s band, though not at the day’s high. The market capitalisation at Rs 4,195.25 crore keeps the company in view among investors who track listed healthcare names with a meaningful market value and a sustained near-high pattern. The current move should be read alongside the streak, not in isolation, because the repeated proximity to the one-year peak is the defining feature here.

What the Repeated 52-Week Highs Show

The latest Univest update shows that Kwality Pharmaceuticals Ltd. has traded within 2% of its 52-week high for a second straight session, and the cumulative move across that streak is 3.69%. That is the clearest way to read the event: not as a single-day breakout story, but as a pattern of the stock staying close to its yearly high across multiple sessions. The latest data confirms that proximity; it does not identify a company-specific trigger for why the pattern is continuing.

For market readers, that matters because repeated near-high trading often keeps the stock on watchlists longer than an isolated spike. It does not automatically imply a fresh rerating or a new operating trend. Instead, it tells you the market is repeatedly valuing the company in the same elevated range over at least two sessions. Since the latest session still sits near the top of the day’s band, the streak remains intact and the share price continues to reflect that persistent high-zone interest in a factual, measurable way.

Another useful lens is the difference between a first-day move and a second straight session near the high. A single-day high can be driven by a short burst in sentiment, but a repeated pattern is more durable as a market signal because it survives another trading day. In this case, the streak is already visible in the price behaviour, while the reason behind it remains unconfirmed in the latest Univest data.

Kwality Pharmaceuticals Ltd. (KPL) Fundamental Analysis

Metric Value
Market Capitalisation Rs 4,195.25 crore
P/E Ratio 45.36x
P/B Ratio 11.29x
ROE 22.67%
ROCE 24.01%
EPS Rs 92.48
Book Value Per Share Rs 371.43
Dividend Yield 0%

Kwality Pharmaceuticals Ltd. (KPL) fundamental metrics show P/E 45.36x, P/B 11.29x, ROE 22.67%, ROCE 24.01%. These figures provide context only and are not a buy or sell signal.

Kwality Pharmaceuticals Ltd. has a market capitalisation of Rs 4,195.25 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 45.36x, P/B at 11.29x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.67% and ROCE of 24.01%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 92.48, book value per share of Rs 371.43, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.53x, median ROE of 10.98%, median ROCE of 12.76%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 45.36x
Benchmark Median P/E 26.53x
Benchmark Average P/E 51x
Benchmark P/E Range 0x to 1,378.1x
Company P/B Ratio 11.29x
Benchmark Median P/B 2.78x
Company ROE 22.67%
Benchmark Median ROE 10.98%
Company ROCE 24.01%
Benchmark Median ROCE 12.76%
Company Market Capitalisation Rs 4,195.25 crore
Benchmark Median Market Cap Rs 789.38 crore

Kwality Pharmaceuticals Ltd. (KPL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Kwality Pharmaceuticals Ltd. (KPL) has a P/E ratio of 45.36x, which is above the benchmark median of 26.53x, a difference of +70.98%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Kwality Pharmaceuticals Ltd. (KPL) has a ROE of 22.67%, which is above the benchmark median of 10.98%, a difference of +106.47%. Kwality Pharmaceuticals Ltd. (KPL) has a ROCE of 24.01%, which is above the benchmark median of 12.76%, a difference of +88.17%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
RPG Life Sciences Ltd. RPGLIFE 4,212.57 37.86 6.03 20.28 26.99
Gufic Biosciences Ltd. GUFICBIO 4,396.39 53.09 5.99 10.14 12.56
SMS Pharmaceuticals Ltd. SMSPHARMA 4,557.58 38.24 5.31 12.49 13.32
Aarti Drugs Ltd. AARTIDRUGS 4,589.51 20.18 2.75 13.36 12.04
Gujarat Themis Biosyn Ltd. GUJTHEM 4,706.29 109.74 4.46 17.41 18.16

Kwality Pharmaceuticals Ltd. (KPL) has a P/E ratio of 45.36x compared with the displayed peer median of 38.24x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 22.67% compares with a peer median of 13.36% across the companies shown in the table. ROCE stood at 24.01% versus the displayed peer median of 13.32%, providing a capital-efficiency comparison. Kwality Pharmaceuticals Ltd. (KPL) has a market capitalisation of Rs 4,195.25 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Kwality Pharmaceuticals Ltd.

  • The stock has traded within 2% of its 52-week high for a second straight session.
  • The cumulative move across the streak is 3.69%, which keeps the near-high pattern in focus.
  • The latest price action is taking place while the stock stays near the top of its recent range.
  • Valuation remains above the peer median on both P/E and P/B.
  • ROE and ROCE are both stronger than the peer medians tracked for the industry.

About Kwality Pharmaceuticals Ltd.

Kwality Pharmaceuticals Ltd. is a listed healthcare company in the Pharmaceuticals & Drugs industry. The stock trades on the NSE and BSE, and its latest market capitalisation stands at Rs 4,195.25 crore. The company is part of a sector where investors usually watch both earnings quality and valuation closely, especially when the share price keeps returning to a one-year high zone.

In the latest figures, the company shows a P/E of 45.36, a P/B of 11.29, ROE of 22.67%, ROCE of 24.01%, EPS of Rs 92.48 and book value of Rs 371.43. Those figures make the company relevant for readers tracking stock performance, market update themes and healthcare names with sustained price strength.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.

Frequently Asked Questions

What does Kwality Pharmaceuticals Ltd. 52 Week High Streak mean?

Ans. It means the stock has traded within 2% of its 52-week high across consecutive sessions. For Kwality Pharmaceuticals Ltd., that pattern has now lasted for a second straight session, which keeps the yearly high zone in focus.

How many sessions has Kwality Pharmaceuticals Ltd. stayed near its 52-week high?

Ans. The stock has stayed within 2% of its 52-week high for two consecutive sessions. The latest Univest reading marks the second straight session in that range. The stock moved -0.07% so far today.

What is the cumulative move across the streak?

Ans. The cumulative move across the streak is 3.69%. That figure captures the full multi-session price change rather than only the latest intraday move.

Does the latest data confirm a company-specific catalyst?

Ans. No. The latest Univest data confirms the repeated near-high price pattern, but it does not establish a company-specific catalyst for the move.

How did the share price trade today?

Ans. The stock traded at Rs 4,192.50, after opening at Rs 4,230 and moving between Rs 4,177.10 and Rs 4,274.75 during the session. The move versus the previous close was marginal.

How does the valuation compare with peers?

Ans. Kwality Pharmaceuticals Ltd. trades above the peer median on both P/E and P/B. Its P/E of 45.36 and P/B of 11.29 are higher than the benchmark medians tracked for the same industry group.

What do the profitability ratios show?

Ans. ROE stands at 22.67% and ROCE at 24.01%, both above the peer medians in the same industry benchmark set. That gives the stock a stronger return profile than many comparable names.

Why do investors track a repeated near-high pattern?

Ans. A repeated near-high pattern keeps a stock in focus because it shows the market is repeatedly valuing it near the same elevated range. Investors often watch whether that pattern is supported by fundamentals, sector context and fresh company updates.

Track Kwality Pharmaceuticals Ltd. (KPL) Share Price on Univest

Use Kwality Pharmaceuticals Ltd. (KPL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.



Leave a Reply Cancel reply